06
Feb

Eleven Biotherapeutics, Revance Therapeutics and Egalet are the latest drug developers to pull off IPOs, raking in a combined $196 million in the busiest week of the biotech boom.

…read more

Source: Three more biotechs snag $196M in a huge week for IPOs

    

0 No comments